Home|Journals|Articles by Year|Audio Abstracts
 

Original Article



Scopoletin from Lasianthus lucidus Blume (Rubiaceae): A potential antimicrobial against multidrug-resistant Pseudomonas aeruginosa

Tiwtawat Napiroon, Markus Bacher, Henrik Balslev, Kwankamol Tawaitakham, Wichai Santimaleeworagun, Srunya Vajrodaya.




Abstract

A bioassay-guided study of stem bark lipophilic extracts led to the isolation of a bioactive compound from Lasianthus lucidus Blume species related to traditional medicine for treatment of wound infections, bleeding and fevers. Scopoletin (7-hydroxy-6-methoxycoumarin) could be isolated from stem bark extract yielding 1.4 µmol/g by dry weight. The minimum inhibitory concentrations of extracts and scopoletin proved to be effective against both strains of Pseudomonas aeruginosa ATCC 27853 (AmpC -lactamase producing strain) and P. aeruginosa DMSC 37166 (clinical strain). They revealed the highest antibacterial effect at 128 µg/ml and morphological changes on bacterial cells were demonstrated by Field Emission Scanning Electron Microscope. The lipophilic extracts and the purified scopoletin from L. lucidus have clear antibacterial activities, especially acting against P. aeruginosa strains. They produce cell lysis, inflated swelling cell walls and cell walls sinking into cells in the same way.

Key words: Ethnomedicines, Infectious diseases, Scopoletin, Lasianthus






Full-text options


Share this Article


Online Article Submission
• ejmanager.com




ejPort - eJManager.com
Refer & Earn
JournalList
About BiblioMed
License Information
Terms & Conditions
Privacy Policy
Contact Us

The articles in Bibliomed are open access articles licensed under Creative Commons Attribution 4.0 International License (CC BY), which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made. To view a copy of this licence, visit http://creativecommons.org/licenses/by/4.0/.